RETINOPATHY OF PREMATURITY (ROP)
Clinical trials for RETINOPATHY OF PREMATURITY (ROP) explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY (ROP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking tiny eyes: Years-Long checkup for premature Babies' vision
Disease control CompletedThis study followed 100 babies for several years after they received treatment for retinopathy of prematurity (ROP), an eye disease affecting premature infants. The main goal was to see how their vision, eye health, and overall development turned out long-term. Researchers checke…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Massive study of 7,070 premature babies aims to halt blindness
Knowledge-focused CompletedThis study observed over 7,000 premature infants to understand which babies are most at risk for a serious eye disease called retinopathy of prematurity (ROP), which can cause blindness. Researchers collected data from hospital eye exams and treatments to analyze risk factors lik…
Matched conditions: RETINOPATHY OF PREMATURITY (ROP)
Sponsor: Alaska Blind Child Discovery • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:23 UTC